Cargando…

Association of chronic liver disease with the prognosis of COVID-19 patients

Detalles Bibliográficos
Autores principales:	Long, Junyu, Sang, Xinting, Zhao, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286900/ https://www.ncbi.nlm.nih.gov/pubmed/34293343 http://dx.doi.org/10.1016/j.jhep.2021.07.011

Ejemplares similares

Reply to: “Association of chronic liver disease with the prognosis of COVID-19 patients”
por: Mallet, Vincent, et al.
Publicado: (2022)

Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
por: Long, Junyu, et al.
Publicado: (2021)

Should people with chronic liver diseases be vaccinated against COVID-19?
por: Chen, Li-Ping, et al.
Publicado: (2021)

Chronic liver disease independently associated with COVID-19 severity: evidence based on adjusted effect estimates
por: Yang, Haiyan, et al.
Publicado: (2021)

Comments on “Effect of type 2 diabetes mellitus in the prognosis of acute-on-chronic liver failure patients in China”
por: Wang, Wei, et al.
Publicado: (2022)

Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
por: Cheung, Ka Shing, et al.
Publicado: (2023)

Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests
por: Wu, Yanyan, et al.
Publicado: (2021)

Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

Liver Function Should Be Monitored When Treating COVID-19 in Chronic HBV-Infected Patients
por: Zou, Xiaojing, et al.
Publicado: (2020)

Liver fibrosis in patients with chronic liver diseases: are laboratory tests useful to diagnosis?
por: Leonardi, Salvatore, et al.
Publicado: (2011)

Relevance of myocardial injury biomarkers to the prognosis of COVID-19 patients
por: Alcaide, Eric, et al.
Publicado: (2022)

COVID-19 and liver disease: Are we missing something?
por: Gupta, Tarana
Publicado: (2022)

Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?
por: Ali, Nurshad
Publicado: (2020)

Reply to: Comments on “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Ding, Ze-yang, et al.
Publicado: (2021)

Letter regarding “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Luo, Meng-Si, et al.
Publicado: (2021)

Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York City
por: Yamada, Takayuki, et al.
Publicado: (2020)

Liver transplantation in COVID-19 positive patients
por: Raveh, Yehuda, et al.
Publicado: (2021)

Relevance of myocardial injury biomarkers to the prognosis of COVID-19 patients. Response
por: Calvo-Fernández, Alicia, et al.
Publicado: (2022)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

The prognosis and short-term efficacy of corticosteroid therapy for COVID-19 patients
por: Jia, Xinyu, et al.
Publicado: (2021)

Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease
por: Liu, Dong, et al.
Publicado: (2022)

Cryptococcus in pleural fluid cytology in a patient with hepatitis B virus-associated chronic liver disease
por: Mutreja, Deepti, et al.
Publicado: (2011)

Elevated baseline renin levels as a possible cause of worse prognosis of COVID-19 in patients with heart disease
por: Guerrero Pérez, Esther, et al.
Publicado: (2021)

Liver Injury in Liver Transplant Patients With COVID-19: A Histopathologic Analysis
por: NG, Alexander
Publicado: (2021)

COVID-19-associated liver injury (COVALI): role of hepatologists
por: Sumida, Yoshio, et al.
Publicado: (2021)

Nosocomial candiduria in chronic liver disease patients at a hepatobilliary center
por: Ahmed, Armin, et al.
Publicado: (2014)

Healthcare for non-Covid-19 liver disease patients during the Covid-19 pandemic in Bangladesh: Current trend and future implications
por: Faizul Huq, A. K. M., et al.
Publicado: (2020)

Letter to the editor in response to: Effect of COVID-19 lockdown on patients with chronic diseases
por: Pathak, Subodh Kumar, et al.
Publicado: (2021)

Liver transplant for alcohol-associated liver disease continues to rise 2 years into the COVID-19 pandemic especially among young adults
por: Lee, Brian P., et al.
Publicado: (2023)

Identification of an m6A-Related Long Noncoding RNA Risk Model for Predicting Prognosis and Directing Treatments in Patients With Colon Adenocarcinoma
por: Liao, Wanying, et al.
Publicado: (2022)

Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?
por: Parsian, Hadi
Publicado: (2011)

Aspartate transaminase to platelet ratio index (APRI) to assess liver fibrosis in patients with chronic liver disease
por: Anania, Caterina, et al.
Publicado: (2011)

Liver injury in remdesivir-treated COVID-19 patients
por: Zampino, Rosa, et al.
Publicado: (2020)

Characteristics of pregnant patients with COVID-19 and liver injury
por: Deng, Guangtong, et al.
Publicado: (2020)

Clinical Characteristics of COVID-19 in Patients With Liver Injury
por: Chen, Peng, et al.
Publicado: (2020)

No Association Between Nonalcoholic Fatty Liver Disease and Severe COVID-19? Something We Might Ignore
por: Gao, Hui, et al.
Publicado: (2022)

Immunity‐modulated sex disparity on COVID‐19 prognosis
por: Liu, Dan, et al.
Publicado: (2020)

Lack of genetic evidence that fatty liver disease predisposes to COVID-19
por: Valenti, Luca, et al.
Publicado: (2020)

Development of immune‐related cell‐based machine learning for disease progression and prognosis of alcoholic liver disease
por: Zhang, Xu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kpte6qnjnp52qi504hb9sln8i1